Liquid Biopsy
News and reporting on cell-free DNA testing.
Senators Reintroduce Bill to Establish Medicare Coverage Pathway for MCED Tests
The bill would allow Medicare to cover MCED tests following approval by FDA and ensure their use would not impact coverage of traditional screenings.
Liquid Biopsy Firms Eye Melanoma for Minimal Residual Disease Testing, Though Questions Remain
Premium
MRD assays show promise in immunotherapy response prediction with the potential to guide dose/treatment escalation with emerging adjuvant approaches.
Freenome, Walgreens Partner to Diversify Cancer Early Detection Studies
The pharmacy firm will lend its recruitment technology and infrastructure to enroll a more diverse patient population, beginning with Freenome's Sanderson Study.
Genomill, Finland's iCAN Partner to Improve Geno1 Cancer Detection With Biobank Samples
The molecular diagnostic firm will use iCAN's database of genomic and clinical data to help improve the sensitivity of its liquid biopsy technology.
Myriad Genetics, MD Anderson Partner to Study MRD Testing in Renal Cell Carcinoma
Researchers will explore whether Myriad's Precise MRD test can be used to inform treatment, monitor disease progression, and track treatment response.